Skip to main content
. 2019 Mar 20;25:2079–2086. doi: 10.12659/MSM.915541

Figure 3.

Figure 3

Knockdown of SNHG16 inhibits proliferation, migration, and invasion and reverses sorafenib resistance in HCC cells. (A) Hep3B and HepG2 cells were transfected with SNHG16 siRNA or a scrambled negative control. The transfection efficiency was detected by qRT-PCR. ** P<0.01. (B) Hep3B and HepG2 cells were transfected with SNHG16 siRNA or a scrambled negative control. Cell growth was detected at days 1–3 after transfection. The data are presented as the mean ±SD. ** P<0.01. (C) HepG2 cells were transfected with SNHG16 siRNA or a scrambled negative control. Cell migration and invasion abilities were analysed by Transwell migration assay (above) and invasion assay (below) (magnification: ×200). ** P<0.01. (D) Hep3B and HepG2 cells were transfected with SNHG16 siRNA or a scrambled negative control. The sensitivity to sorafenib was detected by CCK-8 assay.